Signaling is fundamental to how cells sense and respond to their environment—but in immune cells, those signals must be ...
A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.
A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered ...
Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today ...
Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
Gastrointestinal (GI) cancers remain a major global health burden, accounting for substantial cancer-related morbidity and mortality worldwide. Cell-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results